{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:42Z","timestamp":1792432002009,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.gtc.2016.09.008","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T08:47:25Z","timestamp":1486198045000},"page":"103-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders"],"prefix":"10.1016","volume":"46","author":[{"given":"Uday C.","family":"Ghoshal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjala","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2016.09.008_bib1","doi-asserted-by":"crossref","first-page":"1035S","DOI":"10.1093\/ajcn\/69.5.1035s","article-title":"Developmental microbial ecology of the neonatal gastrointestinal tract","volume":"69","author":"Mackie","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.gtc.2016.09.008_bib2","first-page":"71","article-title":"Gut microbiota: next frontier in understanding human health and development of biotherapeutics","volume":"5","author":"Prakash","year":"2011","journal-title":"Biologics"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2016.09.008_bib3","first-page":"30","article-title":"Diagnosis of small intestinal bacterial overgrowth in the clinical practice","volume":"17","author":"Gabrielli","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib4","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3748\/wjg.v20.i10.2482","article-title":"Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype","volume":"20","author":"Ghoshal","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5217\/ir.2016.14.2.127","article-title":"Pathogenic role of the gut microbiota in gastrointestinal diseases","volume":"14","author":"Nagao-Kitamoto","year":"2016","journal-title":"Intest Res"},{"key":"10.1016\/j.gtc.2016.09.008_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MEG.0000000000000122","article-title":"Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture","volume":"26","author":"Ghoshal","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","article-title":"A\u00a0systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MEG.0000000000000557","article-title":"A\u00a0proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghoshal","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/apt.12456","article-title":"Review article: small intestinal bacterial overgrowth\u2013prevalence, clinical features, current and developing diagnostic tests, and treatment","volume":"38","author":"Grace","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.09.008_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2040622313496126","article-title":"Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance","volume":"4","author":"Sachdev","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.gtc.2016.09.008_bib11","doi-asserted-by":"crossref","first-page":"151085","DOI":"10.1155\/2012\/151085","article-title":"The gut microbiota and irritable bowel syndrome: friend or foe?","volume":"2012","author":"Ghoshal","year":"2012","journal-title":"Int J Inflam"},{"key":"10.1016\/j.gtc.2016.09.008_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5056\/jnm.2010.16.1.40","article-title":"Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea","volume":"16","author":"Ghoshal","year":"2010","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2016.09.008_bib13","first-page":"451","article-title":"Spectrum of malabsorption syndrome among adults & factors differentiating celiac disease & tropical malabsorption","volume":"136","author":"Ghoshal","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.gtc.2016.09.008_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-230X-3-9","article-title":"Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics","volume":"3","author":"Ghoshal","year":"2003","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/00365529609051995","article-title":"Interdigestive and postprandial motility in small-intestinal bacterial overgrowth","volume":"31","author":"Stotzer","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib16","first-page":"6","article-title":"Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time","volume":"25","author":"Ghoshal","year":"2006","journal-title":"Indian J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2016.09.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000081988","article-title":"The pathogenesis of gastrointestinal bacterial overgrowth","volume":"51","author":"Husebye","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.gtc.2016.09.008_bib18","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1023\/A:1021039032413","article-title":"Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth","volume":"47","author":"Pimentel","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI108740","article-title":"The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine","volume":"59","author":"Vantrappen","year":"1977","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.gtc.2016.09.008_bib20","first-page":"435","article-title":"Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth","volume":"5","author":"Pimentel","year":"2009","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.gtc.2016.09.008_bib21","first-page":"63","article-title":"Pathogenesis of tropical sprue: a pilot study of antroduodenal manometry, duodenocaecal transit time & fat-induced ileal brake","volume":"137","author":"Ghoshal","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.gtc.2016.09.008_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1440-1746.2003.03006.x","article-title":"Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time","volume":"18","author":"Ghoshal","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bmj.2.6132.238","article-title":"Delayed small-intestinal transit in tropical malabsorption","volume":"2","author":"Cook","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.gtc.2016.09.008_bib24","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1517\/14656566.2015.1086747","article-title":"The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease","volume":"16","author":"Barboza","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.gtc.2016.09.008_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02031897","article-title":"Gastrointestinal function in patients with progressive systemic sclerosis","volume":"4","author":"Akesson","year":"1985","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MCG.0000000000000334","article-title":"Gastrointestinal manifestations, malnutrition, and role of enteral and parenteral nutrition in patients with scleroderma","volume":"49","author":"Bharadwaj","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11938-004-0018-0","article-title":"Chronic Intestinal Pseudoobstruction","volume":"7","author":"Lyford","year":"2004","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.gtc.2016.09.008_bib29","first-page":"189","article-title":"Small intestinal manifestations of diabetes mellitus","volume":"56","author":"Miller","year":"1983","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.gtc.2016.09.008_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.12938\/bmfh.2015-019","article-title":"Paneth cell alpha-defensins and enteric microbiota in health and disease","volume":"35","author":"Nakamura","year":"2016","journal-title":"Biosci Microbiota Food Health"},{"key":"10.1016\/j.gtc.2016.09.008_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ni797","article-title":"Paneth cell trypsin is the processing enzyme for human defensin-5","volume":"3","author":"Ghosh","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.gtc.2016.09.008_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature01520","article-title":"Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin","volume":"422","author":"Salzman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.gtc.2016.09.008_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12664-011-0111-y","article-title":"Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients","volume":"30","author":"Ghoshal","year":"2011","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib34","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3748\/wjg.v12.i12.1945","article-title":"Clinical characteristics of a group of adults with nodular lymphoid hyperplasia: a single center experience","volume":"12","author":"Rubio-Tapia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jcp.43.1.57","article-title":"Small intestinal bacterial overgrowth in patients with chronic lymphocytic leukaemia","volume":"43","author":"Smith","year":"1990","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.gtc.2016.09.008_bib36","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1046\/j.1440-1746.2002.02750.x","article-title":"Strongyloides stercoralis infestation associated with septicemia due to intestinal transmural migration of bacteria","volume":"17","author":"Ghoshal","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/gut.35.1.23","article-title":"Duodenal bacterial overgrowth during treatment in outpatients with omeprazole","volume":"35","author":"Fried","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2016.09.008_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2016.09.008_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00000441-198506000-00007","article-title":"Review: pathophysiology of diarrhea caused by bacterial overgrowth of the small intestine","volume":"289","author":"Mathias","year":"1985","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1023\/B:DDAS.0000011607.24171.c0","article-title":"IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen","volume":"49","author":"Pimentel","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.mi.31.100177.000543","article-title":"Microbial ecology of the gastrointestinal tract","volume":"31","author":"Savage","year":"1977","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.gtc.2016.09.008_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1572-0241.1999.01016.x","article-title":"Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome","volume":"94","author":"Bouhnik","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11894-012-0284-2","article-title":"Antibiotics for irritable bowel syndrome: rationale and current evidence","volume":"14","author":"Sachdev","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gtc.2016.09.008_bib45","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","article-title":"Small intestinal bacterial overgrowth in patients with irritable bowel syndrome","volume":"56","author":"Posserud","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2016.09.008_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mrm.21041","article-title":"Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy","volume":"56","author":"Bala","year":"2006","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.gtc.2016.09.008_bib47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/00365529709025099","article-title":"Luminal bacteria and small-intestinal permeability","volume":"32","author":"Riordan","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib48","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/nmo.12399","article-title":"Associations between IL-1RA polymorphisms and small intestinal bacterial overgrowth among patients with irritable bowel syndrome from India","volume":"26","author":"Srivastava","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2016.09.008_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5009\/gnl.2009.3.1.14","article-title":"Immune activation and gut microbes in irritable bowel syndrome","volume":"3","author":"Al-Khatib","year":"2009","journal-title":"Gut Liver"},{"key":"10.1016\/j.gtc.2016.09.008_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10620-010-1232-3","article-title":"Abnormal small intestinal permeability in patients with idiopathic malabsorption in tropics (tropical sprue) does not change even after successful treatment","volume":"56","author":"Kumar","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.2009.06133.x","article-title":"Bugs and irritable bowel syndrome: The good, the bad and the ugly","volume":"25","author":"Ghoshal","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2016.09.008_bib52","first-page":"51","article-title":"Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics","author":"Lykova","year":"2005","journal-title":"Eksp Klin Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib53","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1053\/gast.1996.v110.pm8613033","article-title":"Folate synthesized by bacteria in the human upper small intestine is assimilated by the host","volume":"110","author":"Camilo","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.09.008_bib54","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2003.011502","article-title":"A\u00a0link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing","volume":"63","author":"Pimentel","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gtc.2016.09.008_bib55","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2036.2011.04625.x","article-title":"Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture","volume":"33","author":"Choung","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.09.008_bib56","first-page":"139","article-title":"Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial","volume":"52","author":"Majewski","year":"2007","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-230X-10-23","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?","volume":"10","author":"Reddymasu","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","article-title":"Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates","volume":"65","author":"Vandeputte","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2016.09.008_bib59","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10620-013-2960-y","article-title":"The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth","volume":"59","author":"Gabbard","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5056\/jnm15020","article-title":"Small intestinal bacterial overgrowth diagnosed by glucose hydrogen breath test in post-cholecystectomy Patients","volume":"21","author":"Sung","year":"2015","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2016.09.008_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1572-0241.2003.07379.x","article-title":"High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal","volume":"98","author":"Tursi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1756283X11422264","article-title":"A\u00a0review of rifaximin and bacterial overgrowth in poorly responsive celiac disease","volume":"5","author":"Chang","year":"2012","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib63","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","article-title":"How to interpret hydrogen breath tests","volume":"17","author":"Ghoshal","year":"2011","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2016.09.008_bib64","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","article-title":"Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/cs0950165","article-title":"Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study","volume":"95","author":"Lu","year":"1998","journal-title":"Clin Sci (lond)"},{"key":"10.1016\/j.gtc.2016.09.008_bib66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.2009.205476","article-title":"Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS","volume":"60","author":"Yu","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2016.09.008_bib67","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/nmo.12516","article-title":"Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test","volume":"27","author":"Erdogan","year":"2015","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.gtc.2016.09.008_bib68","first-page":"124","article-title":"Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome","volume":"19","author":"Ning","year":"2016","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.gtc.2016.09.008_bib69","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/nmo.12331","article-title":"A\u00a0study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients","volume":"26","author":"Zhao","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2016.09.008_bib70","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3748\/wjg.v21.i15.4574","article-title":"Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients","volume":"21","author":"Schatz","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib71","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00535-009-0097-8","article-title":"Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test","volume":"44","author":"Berthold","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib72","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.mayocp.2015.04.016","article-title":"Therapeutic effects and mechanisms of action of rifaximin in gastrointestinal diseases","volume":"90","author":"DuPont","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2016.09.008_bib73","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijantimicag.2013.12.008","article-title":"In\u00a0vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth","volume":"43","author":"Pistiki","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2016.09.008_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.13437","article-title":"Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea","volume":"43","author":"Pimentel","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.09.008_bib75","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/j.gastro.2016.02.028","article-title":"The intestinal microenvironment and functional gastrointestinal disorders","volume":"150","author":"Barbara","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.09.008_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2005.02516.x","article-title":"Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth","volume":"22","author":"Lauritano","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.09.008_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2016.09.008_bib78","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.gtc.2016.09.008_bib79","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2036.2000.00751.x","article-title":"Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth","volume":"14","author":"Di Stefano","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.09.008_bib80","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2036.2010.04436.x","article-title":"Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth","volume":"32","author":"Furnari","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2016.09.008_bib81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/15748847113089990048","article-title":"Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation","volume":"8","author":"Rosania","year":"2013","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.gtc.2016.09.008_bib82","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0016-5085(99)70336-7","article-title":"Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial","volume":"117","author":"Attar","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2016.09.008_bib83","doi-asserted-by":"crossref","first-page":"8020","DOI":"10.3390\/nu7095380","article-title":"Lactose intolerance in adults: biological mechanism and dietary management","volume":"7","author":"Deng","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.gtc.2016.09.008_bib84","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2008.02030.x","article-title":"Small intestinal bacterial overgrowth recurrence after antibiotic therapy","volume":"103","author":"Lauritano","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2016.09.008_bib85","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2036.2007.03259.x","article-title":"High dosage rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"25","author":"Scarpellini","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855316300838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855316300838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:50:01Z","timestamp":1568793001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855316300838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0889855316300838"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2016.09.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}